BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2843024)

  • 1. Effect of stress conditions on the course of trophozoite-induced Plasmodium yoelii nigeriensis in mice recently cured of a previous infection.
    Oyerinde JP; Fagbenro-Beyioku AF; Jaji BE
    Afr J Med Med Sci; 1988 Jun; 17(2):97-100. PubMed ID: 2843024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of chloroquine resistance in Plasmodium yoelii nigeriensis.
    Kimbi HK; Fagbenro-Beyioku AF
    East Afr Med J; 1996 Oct; 73(10):634-5. PubMed ID: 8997840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antagonist effect of chloroquine and tumor necrosis factor on hepatic oxidative stress and antioxidant defense in normal and Plasmodium yoelii nigeriensis-infected mice.
    Siddiqi NJ; Alhomida AS; Dutta GP; Pandey VC
    In Vivo; 2002; 16(1):67-70. PubMed ID: 11980364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Status of hepatic oxidative stress and antioxidant defense systems during chloroquine treatment of Plasmodium yoelii nigeriensis infected mice.
    Siddiqi NJ; Alhomida AS
    In Vivo; 1999; 13(6):547-50. PubMed ID: 10757052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental infections of Plasmodium yoelii nigeriensis in mice and rats, and hosts' reactions.
    Fagbenro-Beyioku AF; Oyerinde JP
    Afr J Med Med Sci; 1989 Mar; 18(1):25-32. PubMed ID: 2545080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of host-diet inadequacy on the course of infection of plasmodium yoelii Nigeriensis.
    Fagbenro-Beyioku AF; Oyerinde JP
    West Afr J Med; 1990; 9(2):124-8. PubMed ID: 2268567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different responses of three rodent Plasmodia species, Plasmodium yoelii 17XL, P. berghei NK65 and P. chabaudi AS on treatment with febrifugine and isofebrifugine mixture from Hydrangea macrophylla var. Otaksa leaf in ICR mice.
    Ishih A; Miyase T; Ohori K; Terada M
    Phytother Res; 2003 Jun; 17(6):650-6. PubMed ID: 12820234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Cymbopogon giganteus and Enantia chrantha against chloroquine resistant Plasmodium yoelii nigeriensis.
    Kimbi HK; Fagbenro-Beyioku AF
    East Afr Med J; 1996 Oct; 73(10):636-7. PubMed ID: 8997841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance reversal action of ketoconazole against mefloquine resistance of Plasmodium yoelii nigeriensis.
    Awasthi A; Dutta GP; Bhakuni V; Tripathi R
    Exp Parasitol; 2004; 107(3-4):115-9. PubMed ID: 15363936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute malaria prolongs susceptibility of mice to Plasmodium berghei sporozoite infection.
    Orjih AU
    Clin Exp Immunol; 1985 Jul; 61(1):67-71. PubMed ID: 3899429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azithromycin: antimalarial profile against blood- and sporozoite-induced infections in mice and monkeys.
    Puri SK; Singh N
    Exp Parasitol; 2000 Jan; 94(1):8-14. PubMed ID: 10631075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Antimalarial" medicinal plants and their impact on cell populations in various organs of mice.
    Agomo PU; Idigo JC; Afolabi BM
    Afr J Med Med Sci; 1992 Dec; 21(2):39-46. PubMed ID: 1308080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased parasitaemia and delayed parasite clearance in Schistosoma mansoni and Plasmodium berghei co-infected mice.
    Legesse M; Erko B; Balcha F
    Acta Trop; 2004 Jul; 91(2):161-6. PubMed ID: 15234665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization of albino mice using chloroquine attenuated Plasmodium yoelli nigeriensis.
    Kimbi HK; Fagbenro-Beyioku AF
    East Afr Med J; 1995 Nov; 72(11):742-3. PubMed ID: 8904069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmodium yoelii nigeriensis: biological mechanisms of resistance to chloroquine.
    Beauté-Lafitte A; Altemayer-Caillard V; Chabaud AG; Landau I
    Parasite; 1994 Sep; 1(3):227-33. PubMed ID: 9140489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chloroquine efficacy in Plasmodium berghei NK65-infected ICR mice, with reference to the influence of initial parasite load and starting day of drug administration on the outcome of treatment.
    Ishih A; Suzuki T; Muregi FW; Matsui K; Terada M
    Southeast Asian J Trop Med Public Health; 2006 Jan; 37(1):13-7. PubMed ID: 16771206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimalarial properties of Goniothalamin in combination with chloroquine against Plasmodium yoelii and Plasmodium berghei growth in mice.
    Mohd Ridzuan MA; Ruenruetai U; Noor Rain A; Khozirah S; Zakiah I
    Trop Biomed; 2006 Dec; 23(2):140-6. PubMed ID: 17322815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adoptive transfer of immunity induced with chloroquine attenuated Plasmodium yoelii nigeriensis from immune to immunologically naive mice.
    Kimbi HK; Fagbenro-Beyioku AF
    West Afr J Med; 1997; 16(1):44-7. PubMed ID: 9133824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoregulation in murine malaria. Susceptibility of inbred mice to infection with Plasmodium yoelii depends on the dynamic interplay of host and parasite genes.
    Sayles PC; Wassom DL
    J Immunol; 1988 Jul; 141(1):241-8. PubMed ID: 3379305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimalarial effects of C18 fatty acids on Plasmodium falciparum in culture and on Plasmodium vinckei petteri and Plasmodium yoelii nigeriensis in vivo.
    Krugliak M; Deharo E; Shalmiev G; Sauvain M; Moretti C; Ginsburg H
    Exp Parasitol; 1995 Aug; 81(1):97-105. PubMed ID: 7628573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.